ICHCC/LinkedIn
May 2, 2026, 10:24
From Gene Mutation to Clot Risk in Factor V Leiden – ICHCC
Iranian Comprehensive Hemophilia Care Center shared a post on LinkedIn:
- is the most common inherited blood clotting disorder in populations of European descent, caused by a mutation in the \(F5\) gene. It makes blood more prone to clotting (thrombophilia) because the mutated Factor V protein resists inactivation by protein C.
- While most carriers never experience a clot, it significantly increases the risk of deep vein thrombosis (DVT) and pulmonary embolism.”
Stay updated with Hemostasis Today.
-
Aug 4, 2026, 03:57Rosina Pavia: The Hidden Cardiovascular Risks of Microplastics
-
Aug 4, 2026, 03:13William Aird: Understanding von Willebrand Disease – A Visual Roadmap
-
Aug 4, 2026, 02:16New Report Identifies Key Research Priorities for Venous Thrombosis and Stroke – International Journal of Stroke
-
Aug 4, 2026, 02:15Radovan Malý: Finding the Optimal Aspirin Dose in Acute Coronary Syndrome
-
Aug 4, 2026, 02:14Umair Ahmad: Aspirin for Relief Protection and Prevention
-
Aug 4, 2026, 02:12Heavy Menstrual Bleeding in Adolescents Should Never Be Dismissed as “Just a Normal Period” – ICHCC
-
Aug 4, 2026, 02:12Pablo Corral: Viewing Lp(a) as a Multidimensional Particle
-
Aug 3, 2026, 16:01Your First Steps After an ITP Diagnosis – ITP Support Association
-
Aug 3, 2026, 15:33Christina Crossette-Thambiah: Scientific Excellence and Mentorship at ISTH 2026